{"id":"W3039669474","doi":"10.1002/ijc.33137","title":"Characterization of a dual <scp>BET</scp>/<scp>HDAC</scp> inhibitor for treatment of pancreatic ductal adenocarcinoma","year":2020,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Pharma; Deutschen Konsortium für Translationale Krebsforschung; Ministero dello Sviluppo Economico; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; Deutsche Forschungsgemeinschaft; Ontario Ministry of Economic Development and Innovation; European Synchrotron Radiation Facility; Wellcome Trust; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Deutsche Krebshilfe; Pfizer","keywords":"Bromodomain; BRD4; BET inhibitor; Cancer research; Epigenetics; Chemistry; Chromatin; Biology; Pharmacology; Biochemistry; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000774641,0.0001370964,0.0002576848,0.00008557329,0.0000196311,0.00001868435,0.0001802558,0.00008955106,0.00001485912],"category_scores_gemma":[0.0003384365,0.000118808,0.0002199015,0.00007008795,0.00005624459,0.00002380434,0.00003331568,0.00004193863,0.000001154985],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005681242,"about_ca_system_score_gemma":0.0002289824,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001084044,"about_ca_topic_score_gemma":0.000004627444,"domain_scores_codex":[0.9988009,0.00003366493,0.0005629172,0.0001554228,0.0003280978,0.0001190322],"domain_scores_gemma":[0.9983212,0.00004741076,0.0007495168,0.00008311243,0.0007026815,0.00009610101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001215767,0.0001315273,0.01320357,0.0000288446,0.0005117442,0.000006355636,0.0004305501,0.0000343995,0.9826547,0.00005967237,0.001507224,0.001309857],"study_design_scores_gemma":[0.001903862,0.00123306,0.01179144,0.00006241758,0.00009251314,0.00002850879,0.0001509949,0.00009815747,0.9432178,0.00002999406,0.0413602,0.00003105802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946125,0.001797355,0.001860795,0.0005349806,0.0006342998,0.0002103917,0.0002584557,0.000003347805,0.00008788462],"genre_scores_gemma":[0.9959456,0.000841274,0.0004118746,0.0002097402,0.002041676,0.00002546051,0.0001442316,0.00001965163,0.0003604516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03985298,"threshold_uncertainty_score":0.4844851,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01638396802171311,"score_gpt":0.2740297099845431,"score_spread":0.25764574196283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}